Page last updated: 2024-09-03

1-acetyl-3,2-toluyl-5-fluorouracil and Carcinoma

1-acetyl-3,2-toluyl-5-fluorouracil has been researched along with Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MH; Cheng, YN; Cui, SX; Li, X; Liu, J; Makuuchi, M; Qu, XJ; Tang, W; Tian, ZG; Xu, WF1

Other Studies

1 other study(ies) available for 1-acetyl-3,2-toluyl-5-fluorouracil and Carcinoma

ArticleYear
Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
    European journal of pharmacology, 2007, Nov-21, Volume: 574, Issue:1

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Microsomes, Liver; Prodrugs; Stomach Neoplasms; Xenograft Model Antitumor Assays

2007